1. Population Pharmacokinetics and Exposure Response Assessment of CC‐292, a Potent BTK Inhibitor, in Patients With Chronic Lymphocytic Leukemia. (19th May 2017) Authors: Li, Yan; Ramírez‐Valle, Francisco; Xue, Yongjun; Ventura, Judith I.; Gouedard, Olivier; Mei, Jay; Takeshita, Kenichi; Palmisano, Maria; Zhou, Simon Journal: Journal of clinical pharmacology Issue: Volume 57:Number 10(2017) Page Start: 1279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗